Lamb Peter
- SEC CIK
- 0001387306
No open-market purchases or sales filed in the past year.
Current role at each company
- EXEL Exelixis, Inc.EVP, Scientific Strategy & CSOas of Dec 16, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Lamb Peter as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 16, 2022 (view filing) | Dec 15 | 1 day | Lamb PeterEVP, Scientific Strategy & CSO | SSale | −20.0K | $15.88 | −$317.6K | −4.6%411.0K after | |
| Dec 17, 2021 (view filing) | Dec 15 | 2 days | Lamb PeterEVP, Scientific Strategy & CSO | SSale | −47.5K | $17.44 | −$828.4K | −11.6%363.2K after | |
| Nov 17, 2021 (view filing) | Nov 15 | 2 days | Lamb PeterEVP, Scientific Strategy & CSO | SSale | −47.5K | $18.09 | −$859.3K | −10.4%411.2K after | |
| Oct 15, 2021 (view filing) | Oct 15 | Same day | Lamb PeterEVP, Scientific Strategy & CSO | SSale | −47.5K | $21.92 | −$1.04M | −10.4%411.2K after | |
| Sep 17, 2021 (view filing) | Sep 15 | 2 days | Lamb PeterEVP, Scientific Strategy & CSO | SSale | −47.5K | $20.46 | −$971.9K | −10.9%389.5K after | |
| Aug 18, 2021 (view filing) | Aug 16 | 2 days | Lamb PeterEVP, Scientific Strategy & CSO | SSale | −55.0K | $18.44 | −$1.01M | −12.4%389.5K after | |
| Jul 16, 2021 (view filing) | Jul 15 | 1 day | Lamb PeterEVP, Scientific Strategy & CSO | SSale | −60.0K | $17.47 | −$1.05M | −13.3%389.5K after |